Neurocrine Biosciences (NBIX) Sɔɔtɔ Fɔrɛkɛst
Nɔnyɔ nyɛ$138.08Nɔɔ 25 Gbo 2026 19:59 UTC
Nyuɛ-0.62%
AI forecast: NBIX
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
Neurocrine Biosciences, Inc. (NBIX) researches and develops therapeutic agents for the treatment of psycho-neurological, neuroinflammatory, and neurodegenerative diseases and disorders, as well as for neuroses, depression, Alzheimer’s disease, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
